Lakshmi Kotra

Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The private company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation.

WinSanTor, Inc. operates as a clinical-stage biotechnology company. The firm focuses on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced and others. The company was founded by Stanley Kim, Nigel Calcutt, Paul Fernyhough and Lakshmi P. Kotra in 2011 and is headquartered in San Diego, CA.